139 related articles for article (PubMed ID: 25339428)
1. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study.
Catteau X; Simon P; Noël JC
Diagn Pathol; 2014 Oct; 9():196. PubMed ID: 25339428
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
[TBL] [Abstract][Full Text] [Related]
3. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
Catteau X; Simon P; Noël JC
BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
[TBL] [Abstract][Full Text] [Related]
4. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
Catteau X; Simon P; Vanhaeverbeek M; Noël JC
PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
Yazhou C; Wenlv S; Weidong Z; Licun W
Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
[TBL] [Abstract][Full Text] [Related]
6. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
7. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.
Roozdar A; Hayes MM; Pourseyedei B; Zeinalinejad H; Shamsi Meymandi M; Dabiri B; Dabiri S
Arch Iran Med; 2018 May; 21(5):185-190. PubMed ID: 29738261
[TBL] [Abstract][Full Text] [Related]
8. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.
Ramaswamy A; Moll R; Barth PJ
Virchows Arch; 2003 Oct; 443(4):536-40. PubMed ID: 12898244
[TBL] [Abstract][Full Text] [Related]
9. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx.
Barth PJ; Schenck zu Schweinsberg T; Ramaswamy A; Moll R
Virchows Arch; 2004 Mar; 444(3):231-4. PubMed ID: 14758552
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma.
Koperek O; Scheuba C; Puri C; Birner P; Haslinger C; Rettig W; Niederle B; Kaserer K; Garin Chesa P
Int J Oncol; 2007 Jul; 31(1):59-67. PubMed ID: 17549405
[TBL] [Abstract][Full Text] [Related]
11. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
[TBL] [Abstract][Full Text] [Related]
12. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.
Nimphius W; Moll R; Olbert P; Ramaswamy A; Barth PJ
Virchows Arch; 2007 Feb; 450(2):179-85. PubMed ID: 17149610
[TBL] [Abstract][Full Text] [Related]
13. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
[TBL] [Abstract][Full Text] [Related]
14. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
[TBL] [Abstract][Full Text] [Related]
15. α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma.
Ding L; Zhang Z; Shang D; Cheng J; Yuan H; Wu Y; Song X; Jiang H
J Oral Pathol Med; 2014 May; 43(5):335-43. PubMed ID: 24313357
[TBL] [Abstract][Full Text] [Related]
16. CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast.
Ebrahimsade S; Westhoff CC; Barth PJ
Pathol Res Pract; 2007; 203(9):695-8. PubMed ID: 17656039
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
18. Application of immunohistochemistry for detection of metastases in sentinel lymph nodes of non-advanced breast cancer patients.
Nowikiewicz T; Śrutek E; Zegarski W
Pol J Pathol; 2015 Mar; 66(1):22-9. PubMed ID: 26017876
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma.
Lin XD; Chen SQ; Qi YL; Zhu JW; Tang Y; Lin JY
J Surg Oncol; 2012 Jul; 106(1):94-100. PubMed ID: 22231149
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
Cîmpean AM; Raica M; Nariţa D
Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
